Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Trial to Evaluate a Guideline-Based Colony Stimulating Factor Standing Order Intervention and to Determine the Effectiveness of Colony Stimulating Factor Use as a Prophylaxis for Patients Receiving Chemotherapy With Intermediate Risk for Febrile Neutropenia - Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

NCT02728596 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02728596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Trial to Evaluate a Guideline-Based Colony Stimulating Factor Standing Order Intervention and to Determine the Effectiveness of Colony Stimulating Factor Use as a Prophylaxis for Patients Receiving Chemotherapy With Intermediate Risk for Febrile Neutropenia - Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Lead sponsor
SWOG Cancer Research Network
Phase
Not applicable
Overall status
Completed
Start date
October 7, 2016
Completion date
August 12, 2021
Enrollment
3,665 (actual)
Sites
160

Conditions

As the registry lists them; a condition with its own page is linked.

febrile neutropenia, stage 0 breast cancer, stage 0 colorectal cancer, stage 0 non-small cell lung cancer, stage i colorectal cancer, stage ia breast cancer, stage ia non-small cell lung carcinoma, stage ib breast cancer, stage ib non-small cell lung carcinoma, stage iia breast cancer, stage iia colorectal cancer, stage iia non-small cell lung carcinoma, stage iib breast cancer, stage iib colorectal cancer, stage iib non-small cell lung carcinoma, stage iic colorectal cancer, stage iiia breast cancer, stage iiia colorectal cancer, stage iiia non-small cell lung cancer, stage iiib breast cancer, stage iiib colorectal cancer, stage iiib non-small cell lung cancer, stage iiic breast cancer, stage iiic colorectal cancer, stage iv breast cancer, stage iv non-small cell lung cancer, stage iva colorectal cancer, stage ivb colorectal cancer